NCT00219310
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +19 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
Clinical trial condition
Communicable Diseases
Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.
9,157 public trials
553 recruiting studies
Communicable Diseases trial results
NCT00129818
- Conditions
- Communicable Diseases, DNA Virus Infections, Female Urogenital Diseases, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Orlando Clinical Research Center Orlando, Florida, United States
- IU Center for Clinical STD Research Indianapolis, Indiana, United States
- UNC Clinical Research - Raleigh Raleigh, North Carolina, United States
NCT01203319
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified
NCT00098306
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- Pfizer Investigational Site Sacramento, California, United States
- Pfizer Investigational Site San Francisco, California, United States
- Pfizer Investigational Site San Francisco, California, United States
- Pfizer Investigational Site San Francisco, California, United States
NCT00851383
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- University of Rochester Medical Center Rochester, New York, United States
NCT01490008
- Conditions
- Anogenital Warts, Communicable Diseases, Condylomata Acuminata, +17 more
- Locations
-
- CardioSec Clinical Reasearch GmbH Erfurt, Germany
Completed
Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection
NCT01571141
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
- Locations
-
- Consultorio Familiare Terme Vigliatore, A.S.P. 5 Messina, Italy
Completed
Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects
NCT01010399
- Conditions
- Blood-Borne Infections, Communicable Diseases, Dyslipidemias, +18 more
- Locations
-
- Franco Felizarta, MD Bakersfield, California, United States
NCT00001059
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
- Locations
-
- Alabama Therapeutics CRS Birmingham, Alabama, United States
- USC CRS Los Angeles, California, United States
- UCLA CARE Center CRS Los Angeles, California, United States
- Ucsf Aids Crs San Francisco, California, United States
NCT01051921
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
- Locations
-
- Scripps Clinic La Jolla, California, United States
- VA Medical Center, San Diego San Diego, California, United States
- University of Colorado Health Science Center Denver, Colorado, United States
- South Denver Gastroenterology Englewood, Colorado, United States